Clinical Trial Update: A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating BMS-986460 in participants with metastatic castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• BMS-986460

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: RECRUITING